Cargando…

What's in a Name? The Politics of ‘Precision Medicine’

Detalles Bibliográficos
Autores principales:	Chan, Sarah, Erikainen, Sonja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Open Peer Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890300/ https://www.ncbi.nlm.nih.gov/pubmed/29621451 http://dx.doi.org/10.1080/15265161.2018.1431324

Ejemplares similares

Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016)

Two Moral Arguments for a Global Social Cost of Carbon
por: Mintz-Woo, Kian
Publicado: (2018)

Domains of Well-Being in Minimally Conscious Patients: Illuminating a Persistent Problem
por: Graham, Mackenzie
Publicado: (2018)

Reflections on trust and COVID-19: do politics, medicine and the environment need each other?
por: Cole, Alistair, et al.
Publicado: (2020)

In Defense of Best Interests: When Parents and Clinicians Disagree
por: Coulson-Smith, Peta, et al.
Publicado: (2018)

The Determination of Quality of Life and Medical Futility in Disorders of Consciousness: Reinterpreting the Moral Code of Islam
por: Rady, Mohamed Y., et al.
Publicado: (2015)

Justice and Global Health Research
por: Venkatapuram, Sridhar
Publicado: (2016)

“The Danger of Lurking”: Different Conceptualizations of “User Awareness” in Social Media Research
por: Samuel, Gabrielle
Publicado: (2017)

Open peer review commentary on building clinically relevant outcomes across the Alzheimer's disease spectrum
por: Rockwood, Kenneth
Publicado: (2021)

Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
por: Cummings, Jeffrey
Publicado: (2023)

Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions”
por: Gandy, Sam
Publicado: (2023)

Contested futures: envisioning “Personalized,” “Stratified,” and “Precision” medicine
por: Erikainen, Sonja, et al.
Publicado: (2019)

Beyond the hype: ‘acceptable futures’ for AI and robotic technologies in healthcare
por: De Togni, Giulia, et al.
Publicado: (2023)

Towards a feminist philosophy of engagements in health-related research
por: Erikainen, Sonja, et al.
Publicado: (2022)

What do experimental simulations tell us about the effect of neuro/genetic evidence on jurors?
por: Scurich, Nicholas
Publicado: (2018)

What’s in a Name?
por: Bourgeois-Law, Gisèle
Publicado: (2019)

A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing
por: Malanga, Sarah, et al.
Publicado: (2015)

Commentary: Is there a problem Consent in Escrow can solve?
por: Taylor, Holly A.
Publicado: (2015)

Assessing health-state utility: is there a uniquely privileged perspective?
por: Wasserman, David
Publicado: (2020)

Neuroscience cannot answer these questions: a response to G. and R. Murrow's essay hypothesizing a link between dehumanization, human rights abuses and public policy
por: Hoffman, Morris B.
Publicado: (2015)

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research
por: Sarnoff, Joshua D.
Publicado: (2015)

Uterus transplantation: does procreative liberty encompass a right to gestate?
por: Alghrani, Amel
Publicado: (2016)

Informed consent to participation in interventional studies: second-order in a different sense
por: Eyal, Nir
Publicado: (2015)

Peer commentary: in vitro gametogenesis: just another way to have a baby
por: Carbone, June
Publicado: (2016)

‘No, actually your life is going considerably worse’: a comment on Nir Eyal
por: Enoch, David
Publicado: (2020)

Regulating drug promotion to promote the public health: a response to Bennett et al.
por: Zettler, Patricia J.
Publicado: (2015)

We should not vaccinate the young to protect the old: a response to Giubilini, Savulescu, and Wilkinson
por: de Miguel Beriain, Iñigo
Publicado: (2021)

Reporting, recording, and communication of COVID-19 cases in workplace: data protection as a moving target
por: Shabani, Mahsa, et al.
Publicado: (2020)

Forschung! Was geht mich das an? - Research: What is there me?
por: Charitos, Panagiotis, et al.
Publicado: (2018)

Is it ‘gene therapy’?
por: Sherkow, Jacob S, et al.
Publicado: (2018)

Science wars—How much risk should soldiers be exposed to in military experimentation?
por: Savulescu, Julian
Publicado: (2015)

Dehumanization: its operations and its origins
por: Simpson, Robert Mark
Publicado: (2015)

Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016)

Hate speech, volition, and neurology
por: Roginsky, Alexandra B., et al.
Publicado: (2015)

Buttressing regulation of cognitive enhancement devices with principles of harm reduction
por: Fitz, Nicholas S., et al.
Publicado: (2014)

Regulation of cognitive enhancement devices: commentary
por: Johnson, Reuben, et al.
Publicado: (2014)

Medical regulation of cognitive enhancement devices: some concerns
por: King, Mike, et al.
Publicado: (2014)

The brain, cognitive enhancement devices, and European regulation
por: Kuersten, Andreas, et al.
Publicado: (2014)

Outstanding questions concerning the regulation of cognitive enhancement devices
por: De Ridder, Dirk, et al.
Publicado: (2014)

Environmental neuroethics: changing the environment—changing the brain Recommendations submitted to the Presidential Commission for the Study of Bioethical Issues
por: Illes, Judy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2vonv69mjdtb5q23up4fsmu94l